| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A case for investment in clinical metagenomics in low-income and middle-income countries
|
Marais, Gert
|
|
|
4 |
3 |
p. e192-e199
|
article
|
| 2 |
Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis
|
Langford, Bradley J
|
|
|
4 |
3 |
p. e179-e191
|
article
|
| 3 |
Correction to Lancet Microbe 2021; 2: e331–41
|
|
|
|
4 |
3 |
p. e136
|
article
|
| 4 |
Correction to Lancet Microbe 2022; 3: e578–87
|
|
|
|
4 |
3 |
p. e136
|
article
|
| 5 |
Correction to Lancet Microbe 2023; published online Jan 16. https://doi.org/10.1016/S2666-5247(22)00384-6
|
|
|
|
4 |
3 |
p. e136
|
article
|
| 6 |
COVID-19 lateral flow IgG seropositivity and serum neutralising antibody responses after primary and booster vaccinations in Chile: a cross-sectional study
|
Sauré, Denis
|
|
|
4 |
3 |
p. e149-e158
|
article
|
| 7 |
Dissemination of the mobilised RND efflux pump gene cluster tmexCD-toprJ among Klebsiella pneumoniae
|
Liu, Chao
|
|
|
4 |
3 |
p. e135
|
article
|
| 8 |
First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2
|
Smit, Merel J
|
|
|
4 |
3 |
p. e140-e148
|
article
|
| 9 |
Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study
|
Reyes, Jinnethe
|
|
|
4 |
3 |
p. e159-e170
|
article
|
| 10 |
Hospital wastewater as a reservoir for the tigecycline resistance gene cluster tmexCD-toprJ
|
Wu, Yuchen
|
|
|
4 |
3 |
p. e134
|
article
|
| 11 |
Mpox screening in high-risk populations finds no asymptomatic cases
|
Van Dijck, Christophe
|
|
|
4 |
3 |
p. e132-e133
|
article
|
| 12 |
Neglected tropical diseases: progress and expectations
|
Folahan, Faith Feranmi
|
|
|
4 |
3 |
p. e137-e138
|
article
|
| 13 |
Omicron sublineage recombinant XBB evades neutralising antibodies in recipients of BNT162b2 or CoronaVac vaccines
|
Zhang, Xiaojuan
|
|
|
4 |
3 |
p. e131
|
article
|
| 14 |
Pasteurisation: Pasteur's greatest contribution to health
|
Currier, Russell
|
|
|
4 |
3 |
p. e129-e130
|
article
|
| 15 |
Solidarity Against Ebola: an update
|
Samarasekera, Udani
|
|
|
4 |
3 |
p. e139
|
article
|
| 16 |
Species-specific immunogenicity and protective efficacy of a vesicular stomatitis virus-based Sudan virus vaccine: a challenge study in macaques
|
Marzi, Andrea
|
|
|
4 |
3 |
p. e171-e178
|
article
|
| 17 |
The unregulated potential of phages
|
The Lancet Microbe,
|
|
|
4 |
3 |
p. e126
|
article
|
| 18 |
Transferable exclusivity extensions to stimulate antibiotic research and development: what is at stake?
|
Anderson, Michael
|
|
|
4 |
3 |
p. e127-e128
|
article
|
Journal description